AI and accelerated computing are transforming the bio/pharmaceutical sector by addressing organizational, technological, and ...

"The threshold debate in Norway" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

The latest update is out from Fusen Pharmaceutical Co., Ltd. ( ($HK:1652) ). Fusen Pharmaceutical Co., Ltd. announced the approval of its ...

The draft guidance, which is touted as a way to reduce the cost and time-associated burden of biosimilar development, has ...

Laxxon Medical, a leading pharmaceutical technology company, pioneering a new generation of advanced oral drug delivery systems, today announced that it will be attending BIO-Europe 2025 and the ...

Regeneron has once again received a complete response letter (CRL) from the US Food and Drug Administration (FDA) for the ...

"Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer" was originally created and published by Pharmaceutical ...

South Africa's biggest pharmaceutical producer Aspen Pharmacare said on Friday it had reached a 25 million euro ($29.2 ...

In today’s Pharmaceutical Executive Daily, we cover Thermo Fisher’s $8 billion agreement to acquire Clario Holdings, Eli ...

Researchers at the Indian Institute of Science (IISc) have developed a highly efficient cell-free enzyme system that converts ...

Drug company Eli Lilly and NVIDIA announced a new partnership to build a supercomputer for drug research. Drug manufacturer ...

Boston-based biotech firm Manifold Bio announced on Monday that it will partner with Swiss pharmaceutical giant Roche to develop a drug for neurological disease using technology driven by artificial ...